BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30561764)

  • 1. Aging-Related Expression of Twinfilin-1 Regulates Cholangiocyte Biological Response to Injury.
    Maroni L; Pinto C; Giordano DM; Saccomanno S; Banales JM; Spallacci D; Albertini MC; Orlando F; Provinciali M; Milkiewicz M; Melum E; Labiano I; Milkiewicz P; Rychlicki C; Trozzi L; Scarpelli M; Benedetti A; Svegliati Baroni G; Marzioni M
    Hepatology; 2019 Sep; 70(3):883-898. PubMed ID: 30561764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: possible implications for sclerosing cholangitis.
    Marzioni M; Saccomanno S; Agostinelli L; Rychlicki C; De Minicis S; Pierantonelli I; Trauner M; Fickert P; Müller T; Shanmukhappa K; Trozzi L; Candelaresi C; Baroni GS; Benedetti A
    J Hepatol; 2013 Apr; 58(4):750-6. PubMed ID: 23207146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of hepatic stem cell factor by Vivo-Morpholino treatment inhibits mast cell migration and decreases biliary damage/senescence and liver fibrosis in Mdr2
    Meadows V; Kennedy L; Hargrove L; Demieville J; Meng F; Virani S; Reinhart E; Kyritsi K; Invernizzi P; Yang Z; Wu N; Liangpunsakul S; Alpini G; Francis H
    Biochim Biophys Acta Mol Basis Dis; 2019 Dec; 1865(12):165557. PubMed ID: 31521820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WNT7B Regulates Cholangiocyte Proliferation and Function During Murine Cholestasis.
    Kosar K; Cornuet P; Singh S; Lee E; Liu S; Gayden J; Sato T; Freyberg Z; Arteel G; Nejak-Bowen K
    Hepatol Commun; 2021 Dec; 5(12):2019-2034. PubMed ID: 34558852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of p16 Decreases Biliary Damage and Liver Fibrosis in the Mdr2
    Kyritsi K; Francis H; Zhou T; Ceci L; Wu N; Yang Z; Meng F; Chen L; Baiocchi L; Kundu D; Kennedy L; Liangpunsakul S; Wu C; Glaser S; Alpini G
    Gene Expr; 2020 Nov; 20(2):89-103. PubMed ID: 32393417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the developmental pathway neurogenin-3/microRNA-7a regulates cholangiocyte proliferation in response to injury.
    Marzioni M; Agostinelli L; Candelaresi C; Saccomanno S; De Minicis S; Maroni L; Mingarelli E; Rychlicki C; Trozzi L; Banales JM; Benedetti A; Baroni GS
    Hepatology; 2014 Oct; 60(4):1324-35. PubMed ID: 24925797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear Translocation of RELB Is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice.
    Elßner C; Goeppert B; Longerich T; Scherr AL; Stindt J; Nanduri LK; Rupp C; Kather JN; Schmitt N; Kautz N; Breuhahn K; Ismail L; Heide D; Hetzer J; García-Beccaria M; Hövelmeyer N; Waisman A; Urbanik T; Mueller S; Gdynia G; Banales JM; Roessler S; Schirmacher P; Jäger D; Schölch S; Keitel V; Heikenwalder M; Schulze-Bergkamen H; Köhler BC
    Gastroenterology; 2019 Mar; 156(4):1190-1205.e14. PubMed ID: 30445013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting senescent cholangiocytes and activated fibroblasts with B-cell lymphoma-extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2
    Moncsek A; Al-Suraih MS; Trussoni CE; O'Hara SP; Splinter PL; Zuber C; Patsenker E; Valli PV; Fingas CD; Weber A; Zhu Y; Tchkonia T; Kirkland JL; Gores GJ; Müllhaupt B; LaRusso NF; Mertens JC
    Hepatology; 2018 Jan; 67(1):247-259. PubMed ID: 28802066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis.
    Tabibian JH; O'Hara SP; Splinter PL; Trussoni CE; LaRusso NF
    Hepatology; 2014 Jun; 59(6):2263-75. PubMed ID: 24390753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes.
    Maroni L; Agostinelli L; Saccomanno S; Pinto C; Giordano DM; Rychlicki C; De Minicis S; Trozzi L; Banales JM; Melum E; Karlsen TH; Benedetti A; Baroni GS; Marzioni M
    Am J Pathol; 2017 Feb; 187(2):366-376. PubMed ID: 27912077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockout of secretin receptor reduces biliary damage and liver fibrosis in Mdr2
    Zhou T; Wu N; Meng F; Venter J; Giang TK; Francis H; Kyritsi K; Wu C; Franchitto A; Alvaro D; Marzioni M; Onori P; Mancinelli R; Gaudio E; Glaser S; Alpini G
    Lab Invest; 2018 Nov; 98(11):1449-1464. PubMed ID: 29977037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2
    Zhou T; Kyritsi K; Wu N; Francis H; Yang Z; Chen L; O'Brien A; Kennedy L; Ceci L; Meadows V; Kusumanchi P; Wu C; Baiocchi L; Skill NJ; Saxena R; Sybenga A; Xie L; Liangpunsakul S; Meng F; Alpini G; Glaser S
    EBioMedicine; 2019 Oct; 48():130-142. PubMed ID: 31522982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of Ductular Reaction by Stem Cell Derived Extracellular Vesicles in MDR2 Knockout Mice via Lethal-7 microRNA.
    McDaniel K; Wu N; Zhou T; Huang L; Sato K; Venter J; Ceci L; Chen D; Ramos-Lorenzo S; Invernizzi P; Bernuzzi F; Wu C; Francis H; Glaser S; Alpini G; Meng F
    Hepatology; 2019 Jun; 69(6):2562-2578. PubMed ID: 30723922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular senescence in the cholangiopathies.
    Bogert PS; O'Hara SP; LaRusso NF
    Curr Opin Gastroenterol; 2022 Mar; 38(2):121-127. PubMed ID: 35098933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy and senescence in fibrosing cholangiopathies.
    Nakanuma Y; Sasaki M; Harada K
    J Hepatol; 2015 Apr; 62(4):934-45. PubMed ID: 25435435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice.
    Guicciardi ME; Krishnan A; Bronk SF; Hirsova P; Griffith TS; Gores GJ
    Cell Death Dis; 2017 Jan; 8(1):e2535. PubMed ID: 28055006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells.
    Wan Y; Meng F; Wu N; Zhou T; Venter J; Francis H; Kennedy L; Glaser T; Bernuzzi F; Invernizzi P; Glaser S; Huang Q; Alpini G
    Hepatology; 2017 Aug; 66(2):528-541. PubMed ID: 28256736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of mast cell-secreted histamine decreases biliary proliferation and fibrosis in primary sclerosing cholangitis Mdr2(-/-) mice.
    Jones H; Hargrove L; Kennedy L; Meng F; Graf-Eaton A; Owens J; Alpini G; Johnson C; Bernuzzi F; Demieville J; DeMorrow S; Invernizzi P; Francis H
    Hepatology; 2016 Oct; 64(4):1202-1216. PubMed ID: 27351144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senescent cholangiocytes release extracellular vesicles that alter target cell phenotype via the epidermal growth factor receptor.
    Al Suraih MS; Trussoni CE; Splinter PL; LaRusso NF; O'Hara SP
    Liver Int; 2020 Oct; 40(10):2455-2468. PubMed ID: 32558183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation.
    Wu N; Meng F; Zhou T; Han Y; Kennedy L; Venter J; Francis H; DeMorrow S; Onori P; Invernizzi P; Bernuzzi F; Mancinelli R; Gaudio E; Franchitto A; Glaser S; Alpini G
    FASEB J; 2017 Oct; 31(10):4305-4324. PubMed ID: 28634212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.